In recent years, it has been found that CHEK1 may play a role in colorectal cancer by affecting cell cycle regulation, and it is closely related to the development and progression of CRC.[44]CHEK1 is an important therapeutic target in gliomas. This evidence concerns the gene CHEK1 and colorectal carcinoma.